Refractory Crohn’s Disease: Perspectives, Unmet Needs and Innovations
Open Access
- 1 October 2024
- journal article
- review article
- Published by Taylor & Francis in Clinical and Experimental Gastroenterology
- Vol. ume 17, 261-315
Abstract
Crohn’s disease (CD) is a complex, chronic inflammatory bowel disease characterized by unpredictable flare-ups and periods of remission. Despite advances in treatment, CD remains a significant health burden, leading to substantial direct healthcare costs and out-of-pocket expenses for patients, especially in the first-year post-diagnosis. The impact of CD on patients’ quality of life is profound, with significant reductions in physical, emotional, and social well-being. Despite advancements in therapeutic options, including biologics, immunomodulators, and small molecules, many patients struggle to achieve or maintain remission, leading to a considerable therapeutic ceiling. This has led to an increased focus on novel and emerging treatments. This context underscores the importance of exploring advanced and innovative treatment options for managing refractory CD. By examining the latest approaches, including immunomodulators, combination therapies, stem cell therapies, and emerging treatments like fecal microbiota transplantation and dietary interventions, there is an opportunity to gain a comprehensive understanding of how best to address and manage refractory cases of CD.Keywords
This publication has 321 references indexed in Scilit:
- Fecal transplantation for treatment of inflammatory bowel diseaseCochrane Database of Systematic Reviews, 2023
- Stem cell transplantation for induction of remission in medically refractory Crohn’s diseaseCochrane Database of Systematic Reviews, 2022
- Fecal microbiota transplantation results in bacterial strain displacement in patients with inflammatory bowel diseasesFEBS Open Bio, 2019
- Enteral nutritional therapy for induction of remission in Crohn's diseaseCochrane Database of Systematic Reviews, 2018
- Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn DiseaseJAMA, 2015
- Effect of Thalidomide on Clinical Remission in Children and Adolescents With Refractory Crohn DiseaseJAMA, 2013
- Cyclosporine for induction of remission in Crohn's diseaseCochrane Database of Systematic Reviews, 2005
- American Experience With Low-Dose Thalidomide Therapy for Severe Cutaneous Lupus ErythematosusArchives of Dermatology, 1999
- Cutaneous Sarcoidosis Successfully Treated With Low Doses of ThalidomideArchives of Dermatology, 1998
- Thalidomide Effects in Behçet's Syndrome and Pustular VasculitisArchives of internal medicine (1960), 1986